Carbon nanotubes as vaccine scaffolds
- PMID: 23899863
- PMCID: PMC3855883
- DOI: 10.1016/j.addr.2013.07.013
Carbon nanotubes as vaccine scaffolds
Abstract
Carbon nanotubes display characteristics that are potentially useful in their development as scaffolds for vaccine compositions. These features include stability in vivo, lack of intrinsic immunogenicity, low toxicity, and the ability to be appended with multiple copies of antigens. In addition, the particulate nature of carbon nanotubes and their unusual properties of rapid entry into antigen-presenting cells, such as dendritic cells, make them especially useful as carriers of antigens. Early attempts demonstrating carbon nanotube-based vaccines can be used in both infectious disease settings and cancer are promising.
Keywords: Carbon nanotubes; adjuvants; antigen presenting cells; vaccines.
© 2013.
References
-
- Mackall CL. Spreading the wealth: Antigen discovery in adult tumors can help hone the search for pediatric tumor antigens. J. Immunother. 2001;24:281. - PubMed
-
- Farkas AM, Finn OJ. Vaccines based on abnormal self-antigens as tumor-associated antigens: Immune regulation. Semin. Immunol. 2010;22:125. - PubMed
-
- Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007;449:419. - PubMed
-
- Melief CJM. Cancer immunotherapy by dendritic cells. Immunity. 2008;29:372. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
